Financial Ratios Tactile Systems Technology, Inc.
Equities
TCMD
US87357P1003
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.96 USD | +0.52% |
|
-1.13% | -0.14% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -0.53 | -0.23 | 3.63 | 4.79 | 6.4 | |||||
Return on Total Capital | -0.62 | -0.28 | 4.45 | 5.48 | 7.37 | |||||
Return On Equity % | -9.34 | -14.31 | 18.1 | 8.27 | 8.77 | |||||
Return on Common Equity | -9.34 | -14.31 | 18.1 | 8.27 | 8.77 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 71.24 | 71.31 | 71.11 | 73.96 | 75.91 | |||||
SG&A Margin | 69.01 | 67.76 | 61.65 | 62.51 | 63.71 | |||||
EBITDA Margin % | 0.75 | 2.17 | 8.06 | 9.89 | 10.9 | |||||
EBITA Margin % | -0.35 | 1.17 | 7.06 | 8.87 | 10.01 | |||||
EBIT Margin % | -0.85 | -0.37 | 5.67 | 7.57 | 8.89 | |||||
Income From Continuing Operations Margin % | -5.68 | -7.24 | 10.39 | 5.79 | 5.79 | |||||
Net Income Margin % | -5.68 | -7.24 | 10.39 | 5.79 | 5.79 | |||||
Net Avail. For Common Margin % | -5.68 | -7.24 | 10.39 | 5.79 | 5.79 | |||||
Normalized Net Income Margin | -0.69 | -0.92 | 3.03 | 5.01 | 5.94 | |||||
Levered Free Cash Flow Margin | 2.3 | 11.77 | 4.13 | 8.6 | 10.5 | |||||
Unlevered Free Cash Flow Margin | 2.46 | 12.45 | 4.13 | 9.05 | 10.69 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.99 | 0.99 | 1.02 | 1.01 | 1.15 | |||||
Fixed Assets Turnover | 7.2 | 8.49 | 10.41 | 12.32 | 16.02 | |||||
Receivables Turnover (Average Receivables) | 3.57 | 3.71 | 4.28 | 5.01 | 5.53 | |||||
Inventory Turnover (Average Inventory) | 3.17 | 3.34 | 3.47 | 3.7 | 4.86 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.29 | 1.86 | 3.54 | 4.36 | 4.03 | |||||
Quick Ratio | 2.62 | 1.44 | 2.88 | 3.78 | 3.49 | |||||
Operating Cash Flow to Current Liabilities | 0.08 | 0.08 | 0.87 | 1 | 1.05 | |||||
Days Sales Outstanding (Average Receivables) | 102.2 | 98.29 | 85.34 | 72.98 | 65.96 | |||||
Days Outstanding Inventory (Average Inventory) | 115.21 | 109.13 | 105.07 | 98.8 | 75.16 | |||||
Average Days Payable Outstanding | 27.81 | 36.66 | 38.6 | 31.09 | 25.92 | |||||
Cash Conversion Cycle (Average Days) | 189.61 | 170.76 | 151.82 | 140.69 | 115.2 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 62.86 | 59.5 | 26.01 | 20.83 | 7.29 | |||||
Total Debt / Total Capital | 38.6 | 37.3 | 20.64 | 17.24 | 6.79 | |||||
LT Debt/Equity | 58.6 | 54.99 | 23.04 | 18.09 | 5.83 | |||||
Long-Term Debt / Total Capital | 35.98 | 34.48 | 18.28 | 14.97 | 5.43 | |||||
Total Liabilities / Total Assets | 47.51 | 52.39 | 31.2 | 27.3 | 20.09 | |||||
EBIT / Interest Expense | -3.32 | -0.33 | - | 10.64 | 28.21 | |||||
EBITDA / Interest Expense | 9.7 | 3.37 | - | 15.57 | 38.08 | |||||
(EBITDA - Capex) / Interest Expense | 5.74 | 2.72 | - | 14.43 | 35.78 | |||||
Total Debt / EBITDA | 15.65 | 7.89 | 1.96 | 1.39 | 0.4 | |||||
Net Debt / EBITDA | 10.17 | 5.49 | -0.41 | -1.52 | -1.71 | |||||
Total Debt / (EBITDA - Capex) | 26.45 | 9.79 | 2.15 | 1.5 | 0.43 | |||||
Net Debt / (EBITDA - Capex) | 17.19 | 6.82 | -0.46 | -1.64 | -1.82 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 11.18 | 18.61 | 11.2 | 6.76 | 12.47 | |||||
Gross Profit, 1 Yr. Growth % | 11.26 | 18.73 | 10.89 | 11.05 | 15.44 | |||||
EBITDA, 1 Yr. Growth % | -51.01 | 112.78 | 312.41 | 31.07 | 23.98 | |||||
EBITA, 1 Yr. Growth % | -194.56 | 1.12K | 569.64 | 34.16 | 26.94 | |||||
EBIT, 1 Yr. Growth % | -573.66 | -21.86 | -1.81K | 42.5 | 32 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 1.8K | 51.27 | -259.6 | -40.52 | 12.54 | |||||
Net Income, 1 Yr. Growth % | 1.8K | 51.27 | -259.6 | -40.52 | 12.54 | |||||
Normalized Net Income, 1 Yr. Growth % | -525.42 | 114 | -466.96 | 76.68 | 33.42 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 1.77K | 48.38 | -238.16 | -43.09 | 17.14 | |||||
Accounts Receivable, 1 Yr. Growth % | 13.57 | 14.52 | -19.15 | 3.68 | 0.26 | |||||
Inventory, 1 Yr. Growth % | 3.52 | 20.33 | -2.58 | -17.14 | -24.86 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.46 | -10.85 | -7.58 | -12.19 | -14.94 | |||||
Total Assets, 1 Yr. Growth % | 40.31 | 4.39 | 10.37 | 5.86 | -8.05 | |||||
Tangible Book Value, 1 Yr. Growth % | -64.99 | -7.24 | 189.91 | 23.21 | 4.15 | |||||
Common Equity, 1 Yr. Growth % | 2.79 | -5.32 | 59.51 | 11.85 | 1.06 | |||||
Cash From Operations, 1 Yr. Growth % | -5.83 | 97.99 | 588.33 | 13.39 | 5.3 | |||||
Capital Expenditures, 1 Yr. Growth % | 2.14 | -15.36 | 30.56 | 2.93 | -0.5 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 36.88 | 461.83 | -63.1 | 188.11 | 37.24 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 46.36 | 458.78 | -63.1 | 133.75 | 32.94 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.78 | 14.84 | 14.85 | 8.96 | 9.58 | |||||
Gross Profit, 2 Yr. CAGR % | 5.08 | 15.11 | 14.74 | 10.97 | 13.22 | |||||
EBITDA, 2 Yr. CAGR % | -68.04 | 153.51 | 196.23 | 132.5 | 27.48 | |||||
EBITA, 2 Yr. CAGR % | -75.48 | -5.35 | 802.05 | 199.73 | 30.5 | |||||
EBIT, 2 Yr. CAGR % | -61.1 | -49.97 | 266 | 394.25 | 37.15 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.76 | 436.81 | 55.38 | -2.57 | -18.19 | |||||
Net Income, 2 Yr. CAGR % | 3.76 | 436.81 | 55.38 | -2.57 | -18.19 | |||||
Normalized Net Income, 2 Yr. CAGR % | -56.78 | 26.59 | 180.23 | 154.62 | 53.53 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 3.51 | 427.08 | 43.18 | -11.33 | -18.35 | |||||
Accounts Receivable, 2 Yr. CAGR % | 22.06 | 14.04 | -3.78 | -8.45 | 1.95 | |||||
Inventory, 2 Yr. CAGR % | 0.41 | 11.61 | 8.27 | -10.16 | -21.1 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 14.87 | 0.57 | -9.23 | -9.91 | -13.57 | |||||
Total Assets, 2 Yr. CAGR % | 26.87 | 21.03 | 7.34 | 8.09 | -1.34 | |||||
Tangible Book Value, 2 Yr. CAGR % | -36.63 | -43.02 | 63.99 | 89 | 13.28 | |||||
Common Equity, 2 Yr. CAGR % | 6.72 | -1.35 | 22.89 | 33.57 | 6.32 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.38 | 36.54 | 269.16 | 179.37 | 9.27 | |||||
Capital Expenditures, 2 Yr. CAGR % | -37.86 | -7.02 | 5.12 | 15.92 | 1.2 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -6.43 | 438.43 | 43.59 | -6.76 | 98.85 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -3.24 | 453.94 | 43.59 | -7.13 | 76.28 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.12 | 9.2 | 13.61 | 12.09 | 10.12 | |||||
Gross Profit, 3 Yr. CAGR % | 13.17 | 9.44 | 13.68 | 13.5 | 12.44 | |||||
EBITDA, 3 Yr. CAGR % | -43.34 | -29.33 | 198.15 | 125.73 | 88.54 | |||||
EBITA, 3 Yr. CAGR % | -47.99 | -38.02 | 81.71 | 377.92 | 125.08 | |||||
EBIT, 3 Yr. CAGR % | -28.35 | -57.28 | 62.49 | 167.25 | 218.29 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 21.27 | 17.65 | 258.28 | 12.82 | 2.23 | |||||
Net Income, 3 Yr. CAGR % | 21.27 | 17.65 | 258.28 | 12.82 | 2.23 | |||||
Normalized Net Income, 3 Yr. CAGR % | -24.25 | -33.42 | 80.49 | 140.29 | 105.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 20.84 | 16.71 | 237.32 | 5.27 | -2.7 | |||||
Accounts Receivable, 3 Yr. CAGR % | 36.56 | 19.49 | 1.69 | -1.35 | -5.63 | |||||
Inventory, 3 Yr. CAGR % | 19.76 | 6.66 | 6.66 | -0.96 | -15.35 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 85.56 | 5.56 | -2.22 | -10.23 | -11.62 | |||||
Total Assets, 3 Yr. CAGR % | 31.64 | 18.89 | 17.36 | 6.84 | 2.42 | |||||
Tangible Book Value, 3 Yr. CAGR % | -19.93 | -28.05 | -1.99 | 49.08 | 54.95 | |||||
Common Equity, 3 Yr. CAGR % | 12.83 | 2.54 | 15.79 | 19.09 | 21.71 | |||||
Cash From Operations, 3 Yr. CAGR % | -33.65 | 27.55 | 134.12 | 149.08 | 101.81 | |||||
Capital Expenditures, 3 Yr. CAGR % | -20.57 | -31.12 | 4.12 | 4.39 | 10.17 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 99.93 | 74.39 | 124.55 | 66.1 | 6.06 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 104.44 | 77.73 | 124.55 | 68.91 | 4.66 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 19.74 | 17.69 | 13.81 | 9.11 | 11.98 | |||||
Gross Profit, 5 Yr. CAGR % | 19.2 | 17 | 13.8 | 10.05 | 13.5 | |||||
EBITDA, 5 Yr. CAGR % | -21.1 | -1.22 | 20.99 | 13.79 | 112.25 | |||||
EBITA, 5 Yr. CAGR % | -30.71 | -7.18 | 30.13 | 16.42 | 59.17 | |||||
EBIT, 5 Yr. CAGR % | -16.23 | -25.28 | 26.58 | 13.75 | 51.84 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 32.62 | 25 | 33.91 | 9.1 | 98.46 | |||||
Net Income, 5 Yr. CAGR % | 32.62 | 25 | 33.91 | 9.1 | 98.46 | |||||
Normalized Net Income, 5 Yr. CAGR % | -11.86 | -2.87 | 20.3 | 13.86 | 69.18 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 31.95 | 23.49 | 29.33 | 4.56 | 91.25 | |||||
Accounts Receivable, 5 Yr. CAGR % | 32.8 | 32.12 | 18.71 | 7.42 | 1.79 | |||||
Inventory, 5 Yr. CAGR % | 24 | 15.94 | 15.02 | -0.42 | -5.45 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 81.44 | 48.64 | 39.4 | -0.92 | -6.93 | |||||
Total Assets, 5 Yr. CAGR % | 27 | 23.59 | 21.32 | 14.44 | 9.49 | |||||
Tangible Book Value, 5 Yr. CAGR % | -5.53 | -10.75 | 6.66 | 5.88 | 3.85 | |||||
Common Equity, 5 Yr. CAGR % | 16.54 | 10.77 | 16.75 | 13.98 | 11.9 | |||||
Cash From Operations, 5 Yr. CAGR % | -17.85 | 4.44 | 31.82 | 74.54 | 72.61 | |||||
Capital Expenditures, 5 Yr. CAGR % | 22.1 | -13.83 | -11.15 | -15.17 | 2.94 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -12.4 | 41.91 | 80.02 | 35.71 | 103.07 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -11.21 | 43.53 | 80.02 | 37.09 | 103.83 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















